Bryn Mawr Trust CO Tekla Life Sciences Investors Transaction History
Bryn Mawr Trust CO
- $5.25 Billion
- Q1 2025
A detailed history of Bryn Mawr Trust CO transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Bryn Mawr Trust CO holds 1,200 shares of HQL stock, worth $15,036. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,200
Previous 1,200
-0.0%
Holding current value
$15,036
Previous $15,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HQL
# of Institutions
91Shares Held
9.06MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.19MShares$40 Million1.12% of portfolio
-
Penserra Capital Management LLC Orinda, CA747KShares$9.36 Million0.17% of portfolio
-
Morgan Stanley New York, NY519KShares$6.5 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY468KShares$5.86 Million0.25% of portfolio
-
Needham Investment Management LLC New York, NY379KShares$4.74 Million0.5% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...